June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
MMP19 Expression in the Human Optic Nerve
Author Affiliations & Notes
  • Ralph Hazlewood
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
    Stephen A. Wynn Institute for Vision Research, Iowa City, IA
  • Kathy Miller
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
    Stephen A. Wynn Institute for Vision Research, Iowa City, IA
  • Robert F Mullins
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
    Stephen A. Wynn Institute for Vision Research, Iowa City, IA
  • Markus H Kuehn
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
    Stephen A. Wynn Institute for Vision Research, Iowa City, IA
  • Lee M Jampol
    Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, IL
  • John H Fingert
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
    Stephen A. Wynn Institute for Vision Research, Iowa City, IA
  • Footnotes
    Commercial Relationships Ralph Hazlewood, None; Kathy Miller, None; Robert Mullins, None; Markus Kuehn, None; Lee Jampol, None; John Fingert, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5548. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ralph Hazlewood, Kathy Miller, Robert F Mullins, Markus H Kuehn, Lee M Jampol, John H Fingert; MMP19 Expression in the Human Optic Nerve. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5548. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: We previously linked MMP19 mutations with a congenital malformation in which the optic disc is deeply excavated known as cavitary optic disc anomaly (CODA). The purpose of this study was to investigate the expression of MMP19, a secreted matrix metalloproteinase, within the optic nerve.

Methods: MMP19 protein expression in the optic nerve was evaluated by immunohistochemistry in sagittal and en face sections of optic nerves obtained from normal human donor eyes. Sections were co-labeled with antibodies directed against glial cells (GFAP), ganglion cell axons (βIII Tubulin), and microglia (CD45). All experiments were conducted in triplicate using three different human donor eyes.

Results: MMP19 immunolabeling was observed throughout the optic nerve including the optic nerve head. Expression was highest in the prelaminar region and laminar region, with much lower levels in the retrolaminar region. Differential MMP19 labeling was also observed in the cross-sections of the optic nerve, with increased signal in the periphery or edges towards the scleral canal and pia mater. Additionally, no significant co-localization was observed between MMP19 and markers of glial cells, ganglion cell axons, or microglia.

Conclusions: Immunohistochemical analysis shows that MMP19 is strongly expressed in the optic nerve head of human donor eyes, the primary site of pathology in CODA patients. No obvious co-localization was observed with markers for cell types that populate the optic nerve, suggesting that MMP19 accumulates primarily within extracellular spaces in the optic nerve. Moreover, the lateral localization of MMP19 within the optic nerve suggests that dysregulation of its enzymatic function might undermine the adhesion between the optic nerve and the scleral canal and promote formation of an excavated optic nerve head - the key feature of CODA.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×